Escitalopram treatment for patients with major depressive disorder: decision trees for treatment algorithm

Week 4 emerges as a key decision point for escitalopram-treated MDD patients, where integration of baseline profiles, early response patterns, and dose parameters allows timely intervention. Our decision tree framework offers a methodological approach for dynamic decision points that warrant prospective validation and extension to other antidepressants.